News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...

Shares of Prime Medicine ( PRME 13.07%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

The company's technology is impressive, but as a clinical-stage biotech, investing comes with elevated risk. Prime Medicine announced yesterday a new preclinical program for treating alpha-1 ...

Africa Oil's merger boosts cash flow, launches a quarterly dividend, and capitalizes on offshore operations in Nigeria. See ...

Shopify stock is down 21%, presenting a buy-the-dip opportunity. At 68x forward earnings, Shopify's valuation is high. See ...

The release of positive FiH data for PM359 in CGD could serve as a significant catalyst for Prime Medicine’s stock. Successful results would not only validate the company’s Prime Editing ...

Chelsea Counsel Co. lifted its holdings in Prime Medicine by 137.4% during the 4th quarter. Chelsea Counsel Co. now owns 186,780 shares of the company’s stock worth $545,000 after buying an ...

PRIME MEDIA Holdings, Inc. said it had obtained approval from the Securities and Exchange Commission (SEC) for its equity restructuring plan. In a stock exchange disclosure on Thursday, the company ...

Shares in cloud technology company Twilio (TWLO) darkened today despite analysts declaring that it is in a prime position to ...

After the boycott’s launch Friday, March 7, Amazon stock underwent a transient 2.12 percent dip, with shares dropping from an ...

The Prime Minister recently spoke to private sector leaders, stressing the shared goal of driving economic growth, boosting investments, supporting s ...